Telavancin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis

被引：17
|
作者：
Twilla, Jennifer D. [2 ,3 ]
Gelfand, Michael S. [1 ,2 ]
Cleveland, Kerry O. [1 ,2 ]
Usery, Justin B. [2 ,3 ]
机构：
[1] Univ Tennessee, Ctr Hlth Sci, Dept Med, Div Infect Dis, Memphis, TN 38163 USA
[2] Methodist Univ Hosp, Memphis, TN USA
[3] Univ Tennessee, Ctr Hlth Sci, Dept Clin Pharm, Memphis, TN 38163 USA
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2011年 / 66卷 / 11期
关键词：
vancomycin; linezolid; daptomycin; tigecycline; lipoglycopeptide;
D O I：
10.1093/jac/dkr329
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：2675 / 2677
页数：4
相关论文
共 50 条
  • [1] Telavancin for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections
    Rodvold, Keith A.
    CLINICAL INFECTIOUS DISEASES, 2015, 61 : S35 - S37
  • [2] Efficacy of telavancin in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis: studies with a rabbit model
    Yin, Li-Yan
    Calhoun, Jason H.
    Thomas, Theodore S.
    Wirtz, Eric D.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (02) : 357 - 360
  • [3] Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with telavancin
    Nace, Heather
    Lorber, Bennett
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (06) : 1315 - 1316
  • [4] Telavancin for the treatment of methicillin-resistant Staphylococcus aureus bone and joint infections
    Harting, Julie
    Fernandez, Francisco
    Kelley, Rob
    Wiemken, Tim
    Peyrani, Paula
    Ramirez, Julio
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2017, 89 (04) : 294 - 299
  • [5] Pharmacokinetic considerations in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis
    Toma, Meredith B.
    Smith, Kelly M.
    Martin, Craig A.
    Rapp, Robert P.
    ORTHOPEDICS, 2006, 29 (06) : 497 - 501
  • [6] Comparative efficacies of telavancin, vancomycin and linezolid in a rabbit model of methicillin-resistant Staphylococcus aureus osteomyelitis
    Yin, L-Y.
    Calhoun, J.
    Thomas, T.
    Wirtz, E.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S503 - S503
  • [7] OSTEOMYELITIS WITH METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS
    FITZPATRICK, DJ
    CAFFERKEY, MT
    TONER, M
    BEATTIE, T
    KEANE, CT
    JOURNAL OF HOSPITAL INFECTION, 1986, 8 (01) : 24 - 30
  • [8] METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS OSTEOMYELITIS
    SHEFTEL, TG
    MADER, JT
    PENNICK, JJ
    CIERNY, G
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 1985, (198) : 231 - 239
  • [9] Methicillin-Resistant Staphylococcus aureus in Foot Osteomyelitis
    Ashong, Chester N.
    Raheem, Shazia A.
    Hunter, Andrew S.
    Mindru, Cezarina
    Barshes, Neal R.
    SURGICAL INFECTIONS, 2017, 18 (02) : 143 - 148
  • [10] Telavancin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA)
    Hooper, Candace Y.
    Smith, Winter J.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2012, 8 : 131 - 137
12345